Title : Severe Skin Toxicity Caused by Sequential Anti-PD-1 Antibody and Alectinib in Non-small-cell Lung Cancer: A Report of Two Cases and a Literature Review.

Pub. Date : 2021 Nov 20

PMID : 34803090






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We conducted an investigator-initiated trial of alectinib, which also has RET kinase-inhibitory activity, against RET-rearranged NSCLC. alectinib ret proto-oncogene Homo sapiens
2 We conducted an investigator-initiated trial of alectinib, which also has RET kinase-inhibitory activity, against RET-rearranged NSCLC. alectinib ret proto-oncogene Homo sapiens
3 Two RET-rearranged NSCLC patients experienced severe skin toxicity with alectinib after first undergoing anti-PD-1 antibody treatment with an ICI. alectinib ret proto-oncogene Homo sapiens